Insmed, Inc. (INSM)
124.03
-1.74
(-1.38%)
USD |
NASDAQ |
Aug 24, 16:00
124.03
0.00 (0.00%)
After-Hours: 20:00
Insmed Price to Book Value : 35.74 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 36.24 |
| August 20, 2026 | 36.04 |
| August 19, 2026 | 37.65 |
| August 18, 2026 | 37.02 |
| August 17, 2026 | 36.98 |
| August 14, 2026 | 35.66 |
| August 13, 2026 | 36.40 |
| August 12, 2026 | 38.12 |
| August 11, 2026 | 38.20 |
| August 10, 2026 | 38.83 |
| August 07, 2026 | 37.78 |
| August 06, 2026 | 38.20 |
| August 05, 2026 | 28.53 |
| August 04, 2026 | 28.46 |
| August 03, 2026 | 28.37 |
| July 31, 2026 | 28.41 |
| July 30, 2026 | 29.25 |
| July 29, 2026 | 29.72 |
| July 28, 2026 | 30.01 |
| July 27, 2026 | 30.18 |
| July 24, 2026 | 30.81 |
| July 23, 2026 | 30.95 |
| July 22, 2026 | 30.73 |
| July 21, 2026 | 31.30 |
| July 20, 2026 | 30.84 |
| Date | Value |
|---|---|
| July 17, 2026 | 31.21 |
| July 16, 2026 | 30.97 |
| July 15, 2026 | 31.64 |
| July 14, 2026 | 31.73 |
| July 13, 2026 | 31.45 |
| July 10, 2026 | 33.31 |
| July 09, 2026 | 34.08 |
| July 08, 2026 | 33.58 |
| July 07, 2026 | 32.52 |
| July 06, 2026 | 32.14 |
| July 02, 2026 | 32.16 |
| July 01, 2026 | 30.83 |
| June 30, 2026 | 30.72 |
| June 29, 2026 | 32.17 |
| June 26, 2026 | 31.76 |
| June 25, 2026 | 32.09 |
| June 24, 2026 | 31.78 |
| June 23, 2026 | 31.38 |
| June 22, 2026 | 30.29 |
| June 18, 2026 | 29.43 |
| June 17, 2026 | 30.24 |
| June 16, 2026 | 29.34 |
| June 15, 2026 | 29.94 |
| June 12, 2026 | 30.06 |
| June 11, 2026 | 29.71 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Alnylam Pharmaceuticals, Inc. | 23.31 |
| United Therapeutics Corp. | 3.421 |
| ACADIA Pharmaceuticals, Inc. | 3.903 |
| Biogen, Inc. | 1.709 |
| Gilead Sciences, Inc. | 15.40 |
Price to Book Value Related Metrics
| PS Ratio | 23.39 |
| Price | 124.03 |
| Earnings Yield | -3.31% |
| Market Cap | 27.07B |